620.80美元4.54(0.74%)
2023/03/31更新
績效 / 1月2.94%
3月0.3%
1年5.23%
晨星評等 - 1.現金0.00%
- 2.股票38.57%
- 3.債券0.00%
- 4.其他61.43%
- 1.美國61.43%
- 2.歐洲不包含歐元區23.07%
- 3.日本5.39%
- 4.英國4.45%
- 5.歐元區3.34%
- 1.健康護理96.14%
- 2.工業2.27%
- 3.基本物料1.15%
- 4.防守性消費0.44%
- 1.UnitedHealth Group Inc8.34%
- 2.Novo Nordisk A/S Class B8.20%
- 3.Roche Holding AG6.78%
- 4.Elevance Health Inc5.39%
- 5.Amgen Inc5.38%
- 6.Gilead Sciences Inc4.97%
- 7.Vertex Pharmaceuticals Inc4.82%
- 8.Regeneron Pharmaceuticals Inc4.78%
- 9.GSK PLC4.45%
- 10.Zoetis Inc Class A3.69%
- 1.現金0.00%
- 2.股票38.57%
- 3.債券0.00%
- 4.其他61.43%
- 1.健康護理96.14%
- 2.工業2.27%
- 3.基本物料1.15%
- 4.防守性消費0.44%
- 1.美國61.43%
- 2.歐洲不包含歐元區23.07%
- 3.日本5.39%
- 4.英國4.45%
- 5.歐元區3.34%
- 1.UnitedHealth Group Inc8.34%
- 2.Novo Nordisk A/S Class B8.20%
- 3.Roche Holding AG6.78%
- 4.Elevance Health Inc5.39%
- 5.Amgen Inc5.38%
- 6.Gilead Sciences Inc4.97%
- 7.Vertex Pharmaceuticals Inc4.82%
- 8.Regeneron Pharmaceuticals Inc4.78%
- 9.GSK PLC4.45%
- 10.Zoetis Inc Class A3.69%